Concepedia

Kristy J. Gotink

KJ

Statistics

Publications

4

Citations

455

H-Index

4

Active since

2011

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

Roswell Park Comprehensive Cancer Center

Kristy J. Gotink is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in tyrosine kinase inhibitors, oncology, and medicine.

Publications per year

2011–2016

4

Publications

4

Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance

Kristy J. Gotink, Henk J. Broxterman, Mariëtte Labots et al. · Clinical Cancer Research · 2011 · 340 citations · Full text

, , +14

Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib

Kristy J. Gotink, Maria Rovithi, Richard R. de Haas et al. · Cellular Oncology · 2015 · 59 citations · Full text

, , +15

Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature

Kristy J. Gotink, Henk J. Broxterman, Richard J. Honeywell et al. · Oncoscience · 2014 · 30 citations · Full text

, , +15

Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer

Mariëtte Labots, Kristy J. Gotink, Henk Dekker et al. · Experimental & Molecular Medicine · 2016 · 26 citations · Full text

, , +17

1–4 of 4